The strange case of Ryan Braun, the 2011 National League Most Valuable Player who tested positive for steroids during the post-season play-offs, once again raises the perplexing ethical issue of fairness when formal procedures concerning alleged wrongdoing are involved.
Braun’s positive test sent a shudder throughout baseball. He was supposed to be one of the game’s rising young “post-steroid era” stars. For Braun to be caught cheating was a discouraging reminder that the game had not left its disastrous days of pumped-up stars and dubious records behind: now the legitimacy of an MVP season was being called into question. Braun vehemently denied the charges (as every positive-testing player has) and appealed them, a move that had been futile in every previous case. To literally everyone’s surprise, however, the three member arbitration panel ruled 2-1 in Braun’s favor. Although the report of the independent arbitrator who cast the deciding vote has yet to be released, the reason Braun prevailed appears to be that the Major League Baseball contractor who had responsibility for sending Braun’s urine samples to the testing facilities had to store them at his house for the weekend because FedEx had closed before he could mail them to the lab. This created a sufficient break in the chain of custody, it seems, to make the results invalid. Continue reading